Pharmaceuticals

Rising Chronic Disease Prevalence Fueling The Growth Of The Market Due To Increasing Patient Demand For Precision Healthcare Is Supporting Development Across The Personalized Genomics Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Personalized Genomics Market By 2030?

The personalized genomics market has experienced significant expansion recently. Projections indicate its value will rise from $9.45 billion in 2025 to $10.96 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.0%. Historically, this expansion has been driven by factors such as the decreasing expenses associated with genetic sequencing, the rising incidence of both chronic and genetic conditions, an increase in genomics research, the development of diagnostic laboratory facilities, and the early embrace of precision medicine strategies.

The personalized genomics market is projected to experience substantial expansion over the coming years, with its size forecast to reach $19.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.7%. This growth during the projection period can be attributed to several factors, including the integration of genomics into routine clinical practice, a rising demand for personalized medicine, advancements in sequencing technologies, the expansion of wellness and ancestry testing, and growing investments by pharmaceutical and biotechnology companies. Key trends anticipated for the forecast timeframe encompass the increasing adoption of direct-to-consumer genetic testing, the growing use of pharmacogenomics in treatment planning, a heightened demand for preventive and predictive healthcare, the wider availability of genetic testing in reproductive health, and a rising consumer awareness of lifestyle and wellness genomics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

Which Growth Factors Are Strengthening The Personalized Genomics Market Landscape?

An increasing incidence of chronic illnesses is anticipated to drive the expansion of the personalized genomics market in the future. These are enduring health conditions necessitating continuous care, encompassing ailments such as diabetes, cardiovascular disease, high blood pressure, and various other intricate health concerns. This surge in chronic ailments primarily stems from an aging populace, inactive lifestyles, inadequate nutrition, and environmental elements that collectively foster the concurrent onset of several conditions. Personalized genomics aids in managing chronic conditions by facilitating extensive genotyping and sequencing, which helps categorize patients based on genetic risk, thereby enabling more accurate diagnoses, focused treatments, and enhanced preventive measures. As an illustration, in April 2025, data from the U.S. Centers for Disease Control and Prevention (CDC), a US-based entity, indicated that 76.4% of U.S. adults, totaling approximately 194 million individuals, were afflicted with at least one of 12 specified chronic conditions, while 51.4% (roughly 130 million) suffered from two or more such conditions. Consequently, the growing occurrence of chronic illnesses is propelling the expansion of the personalized genomics market.

How Are Different Segment Groups Identified Within The Personalized Genomics Market?

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

3) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Coronary Artery Disease Testing

4) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Ancestry Testing

Which Trends Are Contributing To Changes In The Personalized Genomics Market?

Leading companies in the personalized genomics market are concentrating on developing innovative technologies, such as personalized genomics platforms, to offer customized insights into health, well-being, and disease prevention. A personalized genomics platform is a system designed to analyze an individual’s genetic information, thereby providing bespoke insights and recommendations related to health, overall wellness, and disease risk. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostic service company, introduced Geniee Decode Your DNA, a new customized genomics platform. This platform delivers tailored health, nutrition, and medication insights based on one’s genetic profile. It aims to optimize wellness, prevent diseases, and personalize treatments for improved health outcomes.

Who Are The Businesses Driving Activity In The Personalized Genomics Market?

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

Access The Complete Personalized Genomics Market Report:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

What Is The Largest Regional Market In The Personalized Genomics Market?

North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Personalized Genomics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

Browse Through More Reports Similar to the Global Personalized Genomics Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Pharmacogenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Genomics In Cancer Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795